Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
In this video, we share how PerkinElmer Informatics for Clinical Development helps companies implement a Risk-Based Monitoring approach to clinical trial development. Historically, clinical trial monitoring has always depended on 100% source document verification (SDV) and other on-site monitoring functions to ensure patient safety and data integrity – requiring up to 30% of the $2.6 billion it takes to bring a new drug to market.
To watch the full video, choose from the available formats below, and simply click on the corresponding link. You must have the appropriate player to play the file. For more info on video players, here. You may also download the video file, depending on your OS & browser, by right clicking or alt-clicking and choosing save link as.